Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies
Clinical trial NCT03098355 · WITHDRAWN
Trial details
- NCT number
- NCT03098355
- Sponsor
- Zhujiang Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-30
- Primary completion
- 2022-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.